An FDA panel has recommended that the risky and controversial MS drug Tysabri be returned to the market. The panel argued that the decision to use the drug should be made by the doctor and the patient, in spite of evidence that the drug causes a deadly brain disease. If the FDA accepts the panel’s recommendation, it would be only the second time a drug was returned to the market after having been removed for safety reasons.
Admitted to both the California State Bar and the Florida State Bar, Joseph Saunders has also practiced in the United States District Court and the United States Court of Appeals. His philosophy is to provide aggressive, quality representation and seek fair compensation for individuals and their families who have suffered injury or death at the hands of insurance companies, large corporations, medical providers or governmental entities.